NCT05304351: Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
- State
- Under way
- Phase
- Phase 2
- People
- 1,516 taking part
- Started
- 2 Feb 2022
- Primary completion
- 30 Jun 2026
- Arms
- Arm J
- Results
- None posted
- 2 Feb 2022: Trial started
- 31 Mar 2022: Trial registered